Successfully launching new pharmaceutical products and indications has become increasingly complex. Fragmented data, access challenges, evolving patient behavior, and heightened performance expectations have made traditional, linear launch models harder to sustain.
To succeed in this environment, launch teams need a connected view that brings together strategy, analytics, and execution across the full launch lifecycle.
This infographic outlines how IQVIA supports launch excellence through:
· End‑to‑end launch support spanning market access, commercial, real‑world evidence, and medical affairs
· Data‑driven go‑to‑market strategies informed by thousands of prior launches
· Connected platforms and continuous performance measurement to increase coordination, enable course correction, and sustain launch impact
With more than 30 years of experience supporting over 5,000 launches across 120+ therapeutic areas, IQVIA brings a proven, evidence‑driven perspective on what it takes to maximize launch value in today’s market.